Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
<p>Background: We compared the angiotensin receptor-neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. </p><p>Methods: In this double-blind trial, we randomly assigned 8442 patients with...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | Livre |
Publié: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2018-10-18.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |